Sonnet BioTherapeutics Holdings, Inc.(NASDAQ : SONN)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -2.43% | 67.83 | 0.0% | $2120.05m | |
| NVAX | Novavax, Inc. | 7.12% | 133.28 | 96.5% | $1132.56m | |
| SRNE | Sorrento Therapeutics, Inc. | 4.84% | 13.01 | 2.8% | $802.96m | |
| GILD | Gilead Sciences, Inc. | -0.96% | 68.18 | 1.0% | $567.95m | |
| AMGN | Amgen, Inc. | -0.52% | 240.46 | 1.3% | $471.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.24% | 610.89 | 2.7% | $384.77m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.37% | 267.15 | 1.9% | $353.16m | |
| BNTX | BioNTech SE | 2.74% | 71.00 | 0.0% | $353.03m | |
| ILMN | Illumina, Inc. | 2.73% | 353.53 | 3.5% | $351.76m | |
| BIIB | Biogen, Inc. | -1.60% | 288.54 | 1.6% | $350.10m | |
| ATNM | Actinium Pharmaceuticals, Inc. | 3.77% | 9.91 | 13.3% | $236.61m | |
| VXRT | Vaxart, Inc. | -1.20% | 9.09 | 0.0% | $212.23m | |
| EBS | Emergent BioSolutions, Inc. | 4.17% | 134.97 | 6.4% | $199.46m | |
| MCRB | Seres Therapeutics, Inc. | 21.31% | 28.58 | 3.6% | $186.90m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.87% | 101.89 | 2.0% | $163.07m |
Company Profile
Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey.